93 related articles for article (PubMed ID: 29620159)
1. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.
Skarmoutsou E; Bevelacqua V; D' Amico F; Russo A; Spandidos DA; Scalisi A; Malaponte G; Guarneri C
Int J Mol Med; 2018 Jul; 42(1):392-404. PubMed ID: 29620159
[TBL] [Abstract][Full Text] [Related]
2. Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells.
Samon JB; Champhekar A; Minter LM; Telfer JC; Miele L; Fauq A; Das P; Golde TE; Osborne BA
Blood; 2008 Sep; 112(5):1813-21. PubMed ID: 18550850
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
4. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
5. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
[TBL] [Abstract][Full Text] [Related]
6. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.
Yao M; Wang X; Wang X; Zhang T; Chi Y; Gao F
Int J Mol Med; 2015 Jul; 36(1):294-300. PubMed ID: 25902289
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
Suwanjunee S; Wongchana W; Palaga T
Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells.
Yonekura S; Itoh M; Shiratori E; Ohtaka M; Tohda S
BMC Res Notes; 2018 Aug; 11(1):582. PubMed ID: 30103821
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor regulates NIKS keratinocyte proliferation through Notch signaling.
Roy M; King TW
J Surg Res; 2013 Nov; 185(1):6-11. PubMed ID: 23899513
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
Groeneweg JW; Hall TR; Zhang L; Kim M; Byron VF; Tambouret R; Sathayanrayanan S; Foster R; Rueda BR; Growdon WB
Gynecol Oncol; 2014 Jun; 133(3):607-15. PubMed ID: 24667249
[TBL] [Abstract][Full Text] [Related]
11. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
[TBL] [Abstract][Full Text] [Related]
12. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
13. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
[TBL] [Abstract][Full Text] [Related]
14. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
15. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.
Kumano K; Masuda S; Sata M; Saito T; Lee SY; Sakata-Yanagimoto M; Tomita T; Iwatsubo T; Natsugari H; Kurokawa M; Ogawa S; Chiba S
Pigment Cell Melanoma Res; 2008 Feb; 21(1):70-8. PubMed ID: 18353145
[TBL] [Abstract][Full Text] [Related]
16. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
17. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression.
Balint K; Xiao M; Pinnix CC; Soma A; Veres I; Juhasz I; Brown EJ; Capobianco AJ; Herlyn M; Liu ZJ
J Clin Invest; 2005 Nov; 115(11):3166-76. PubMed ID: 16239965
[TBL] [Abstract][Full Text] [Related]
18. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
19. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
Kim HJ; Kim MJ; Kim A; Jung CW; Park S; Koh JS; Myung JK
Cancer Res Treat; 2017 Apr; 49(2):509-517. PubMed ID: 27586674
[TBL] [Abstract][Full Text] [Related]
20. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
